ResMed | RMD - Ebit


ResMed reported $497.6M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Ansell USD 117.3M 39.1M Jun/2024
AtriCure USD 2.49M 2.28M Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
Cochlear AUD 275M 25.5M Dec/2024
Cooper Companies USD 140.4M 35.3M Sep/2025
CSL USD 2.75B 1.35B Dec/2024
Dexcom USD 323M 80.5M Dec/2025
Edwards Lifesciences USD 370.3M 54.8M Dec/2025
Fisher Paykel Healthcare NZD 298.2M 2.8M Dec/2025
Globus Medical USD -117.52M 8.43M Sep/2025
Haemonetics USD 67.4M 13.71M Dec/2025
Hologic USD 240.9M 12.1M Dec/2025
Idexx Laboratories USD 315.6M 39.24M Dec/2025
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 11.76M 521.67M Sep/2025
Intuitive Surgical USD 865.3M 97.5M Dec/2025
Masimo USD 83.7M 19.2M Sep/2025
Medtronic USD 1.74B 40M Dec/2025
Philips EUR 719M 390M Dec/2025
Ramsay Health Care AUD 500.1M 14.8M Dec/2024
ResMed USD 497.6M 35.25M Dec/2025
Sigma Healthcare AUD 809K 13.76M Dec/2024
Sonic Healthcare AUD 423.94M 80.3M Dec/2024
Steris USD 278M 7.1M Dec/2025
Teleflex USD 112.65M 44.3M Sep/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025